Sector: MedicalGenaera Corporation (NASDAQ: GENR)
Headlines
- OTC Select Announces NASDAQ Daily Stock Watch - EBHI, FCEL, GENR, HAYZ, GROW
Jun 10, 2009 01:00 PM | FCEL, GENR
- TapImmune Issued U.S. Patent Relating to Methods for Enhancing an Immune Response and Alseres Pharmaceuticals, Inc. Raises $5 Million
Jul 01, 2008 09:00 AM | GENR, IDEV
- Crucell 2008 Annual General Meeting of Shareholders - Jun 2 2008 9:12AM
Jun 02, 2008 08:59 AM | GENR, NKTR
- CombinatoRx to Present at the Canaccord Adams Diabetes & Obesity Conference and Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
May 30, 2008 11:29 AM | CRXX, GENR, PCOP
- Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call and PDL BioPharma shares hit 5-year low on wider 1Q loss
May 12, 2008 08:59 AM | GENR, PDLI
- Biogen Idec To Report Third Quarter 2007 Financial Results on October 23, 2007 and Genaera to Present at Biotech 2007 and BIO InvestorForum
Oct 08, 2007 09:29 AM | BIIB, GENR, MNKD
- Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust
Jun 12, 2009 08:01 AM | GENR
- Genaera Corporation Announces Results of Special Meeting of Stockholders
Jun 05, 2009 12:27 PM | GENR
- Genaera Receives Non-Compliance Notice From Nasdaq - May 27 2009 10:35AM
May 27, 2009 10:35 AM | GENR
- Genaera Receives Non-Compliance Notice from Nasdaq
May 27, 2009 09:32 AM | GENR
- Genaera Corporation Announces Approval of Plan of Liquidation and Dissolution by Board of Directors
Apr 28, 2009 05:42 PM | GENR
- Genaera Corporation Implements Cash Conservation Plan
Mar 30, 2009 09:02 AM | GENR
- Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph - Mar 9 2009 1:02PM
Mar 09, 2009 12:57 PM | GENR
- Genaera Corporation Announces 2008 Financial Results
Mar 03, 2009 04:01 PM | GENR
- Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
Feb 10, 2009 02:15 PM | GENR
- Genaera to Present at BIO CEO & Investor Conference
Feb 05, 2009 08:01 AM | GENR
- Form 4 GENAERA CORP For: Jun 29 Filed by: Xmark Opportunity Partners, LLC (10K)
Jul 01, 2009 09:38 PM
- Form 4 GENAERA CORP For: Dec 24 Filed by: Xmark Opportunity Partners, LLC (10K)
Mar 05, 2009 12:31 PM
- Form 4 GENAERA CORP For: Dec 24 Filed by: Kaye Mitchell D (10K)
Feb 23, 2009 02:54 PM
- Form 4 GENAERA CORP For: Aug 13 Filed by: Wotton Paul K (10K)
Aug 15, 2008 08:33 AM
- Form 4 GENAERA CORP For: Aug 11 Filed by: Wolfe Henry R (10K)
Aug 13, 2008 03:52 PM
- Form 4 GENAERA CORP For: Aug 11 Filed by: Kelly Leanne M. (10K)
Aug 13, 2008 03:52 PM
- Form 4 GENAERA CORP For: Aug 11 Filed by: Gast Michael J (10K)
Aug 13, 2008 03:50 PM
- Form 4 GENAERA CORP For: Aug 11 Filed by: ARMSTRONG JOHN L JR (10K)
Aug 13, 2008 03:50 PM
- Form 4 GENAERA CORP For: Jun 26 Filed by: Wotton Paul K (10K)
Jun 30, 2008 02:15 PM
- Form 3 GENAERA CORP For: Jun 26 Filed by: Wotton Paul K (10K)
Jun 30, 2008 02:15 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
GENR
|
Compare to S&P
|
| YTD |
-82.35 %
|
-73.98 %
|
| 4 Weeks |
-67.57 %
|
-65.90 %
|
| 12 Weeks |
-78.57 %
|
-79.52 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -5.26 %
|
|
EPS Growth in Last Year: 39.39 %
|
|
Sales Growth in Last Quarter: -53.26 %
|
|
Sales Growth in Last Quarter: -43.42 %
|
|
